Using methyl capture sequencing data [23] (6 NAT, 15 adenoma and 9 CRC samples), significant hypomethylation of predicted LINC00152 promoter was determined in CRC compared to NAT samples (p = 0.0011). The gene discussed is BRD2; the disease is adenoma.